SXSPT01: BD Bard Sentrinex 3D Port Access Dressing

Sign in to add this product to your favorites!
| Price: | $6.00 EACH |
|---|---|
| Quantity: | |
| In Stock: | 65 eaches |
| Expiration: | 05-2027 |
| Express: | Need it tomorrow? Order in next 9 hours 54 minutes and choose overnight shipping at checkout. |
Additional Details
BD Bard Sentrinex 3D Port Access Dressing
Created specifically for port access, this 3D domed dressing is designed to fit over most needle access devices and lay flat against the skin.
- Customized for port access needles, these dressings help protect the access site and secure the infusion needle tubing
- They feature a 3D bubble intended to accommodate the 3D profile of the port access needle
- They are designed to reduce the amount of unnecessary dressing changes, which may help your facility comply with INS standards of practice
- Dressings are included in the AllPoints port access systems
- Made with breathable material that allows moisture vapor and gas exchange with a securement strip to protect the dressing from premature failure due to force exerted by the tubing
AccessGUDID Info
- FDA Product Code: NAD
- FDA Product Code Name: Dressing,wound,occlusive
- GMDN Term Code: 58301
- GMDN Term Name: Synthetic polymer semi-permeable film dressing, adhesive
- GMDN Term Description: A transparent, semi-permeable (i.e., impermeable to fluids, permeable to vapours and gases) covering applied to wounded or diseased tissue intended to provide protection (e.g., from dirt, water) and/or promote healing. It is a thin, clear film made of synthetic polymer material that is covered on one side with a pressure-sensitive adhesive. It may be applied directly to tissue or used in combination with other dressings (e.g., gauze) to protect postsurgical incisions and minor wounds (e.g., cuts, scrapes, burns, skin tears, blisters). It may also be used to secure to skin other devices such as vascular catheters, infusion ports, or tubing. This is a single-use device.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
IN-DATE